Skip to main content
Clinical Trials/CTRI/2024/07/070627
CTRI/2024/07/070627
Recruiting
Phase 4

A comparison of subcutaneous versus intramuscular depot medroxyprogesterone acetate as a choice of contraceptive method - NI

Dr neha kumari0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr neha kumari
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr neha kumari

Eligibility Criteria

Inclusion Criteria

  • Women giving informed consent for receiving DMPA and ready to follow up visits every 3 months and are falling in category 1 or 2 of WHO Medical Eligibility Criteria for injection DMPA in following phases;
  • a.Post menstrual
  • b.Post abortal
  • c.6 weeks post delivery.

Exclusion Criteria

  • Women with prior history of menstrual irregularities.

Outcomes

Primary Outcomes

Not specified

Similar Trials